COVID-19 Plasma Treatment for Immunocompromised Patients

JAMA Network

About The Study: The findings this systematic review and meta-analysis suggest that transfusion of COVID-19 convalescent plasma is associated with mortality benefit for patients who are immunocompromised and have COVID-19.

Authors: Jonathon W. Senefeld, Ph.D., of the Mayo Clinic in Rochester, Minnesota, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link


/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.